ALS Investment Fund
The ALS Investment Fund finances biotech firms developing ALS drugs/diagnostics. Focuses on Europe & US, backed by patients & advised by Life Sciences Partners. Global investments with deep ALS expertise.
Funding Stage: Series A/B, Series C & Beyond
Investor type: VC Firm
Investment Areas: Biotechnology Research, Treating Neurological and Cognitive Disorders, Huntington's disease, Genetic Disorders, Neurodegenerative Diseases
Country: Netherlands
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.